J
Juan Carlos Plana
Researcher at Baylor College of Medicine
Publications - 72
Citations - 9349
Juan Carlos Plana is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Cardiotoxicity & Ejection fraction. The author has an hindex of 28, co-authored 71 publications receiving 7803 citations. Previous affiliations of Juan Carlos Plana include University of Pennsylvania & University of Texas MD Anderson Cancer Center.
Papers
More filters
Journal ArticleDOI
Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
Juan Carlos Plana,Maurizio Galderisi,Ana Barac,Michael S. Ewer,Bonnie Ky,Marielle Scherrer-Crosbie,Javier Ganame,Igal A. Sebag,Deborah A. Agler,Luigi P. Badano,Jose Banchs,Daniela Cardinale,Joseph R. Carver,Manuel D. Cerqueira,Jeanne M. DeCara,Thor Edvardsen,Scott D. Flamm,Thomas Force,Brian P. Griffin,Guy Jerusalem,Jennifer E. Liu,Andreia Magalhaes,Thomas H. Marwick,Liza Y. Sanchez,Rosa Sicari,Hector R. Villarraga,Patrizio Lancellotti +26 more
TL;DR: The noninvasive evaluation of LVEF has gained importance, and notwithstanding the limitations of the techniques used for its calculation, has emerged as the most widely used strategy for monitoring the changes in cardiac function, both during and after the administration of potentially car- diotoxic cancer treatment.
Journal ArticleDOI
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
Juan Carlos Plana,Maurizio Galderisi,Ana Barac,Michael S. Ewer,Bonnie Ky,Marielle Scherrer-Crosbie,Javier Ganame,Igal A. Sebag,Deborah A. Agler,Luigi P. Badano,Jose Banchs,Daniela Cardinale,Joseph R. Carver,Manuel D. Cerqueira,Jeanne M. DeCara,Thor Edvardsen,Scott D. Flamm,Thomas Force,Brian P. Griffin,Guy Jerusalem,Jennifer E. Liu,Andreia Magalhaes,Thomas H. Marwick,Liza Y. Sanchez,Rosa Sicari,Hector R. Villarraga,Patrizio Lancellotti +26 more
TL;DR: The non-invasive evaluation of LVEF has gained importance, and notwithstanding the limitations of the techniques used for its calculation, has emerged as the most widely used strategy for monitoring the changes in cardiac function, both during and after the administration of potentially cardiotoxic cancer treatment.
Journal ArticleDOI
Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review.
Paaladinesh Thavendiranathan,Frédéric Poulin,Ki-Dong Lim,Juan Carlos Plana,Anna Woo,Thomas H. Marwick +5 more
TL;DR: The value of echocardiographicMyocardial deformation parameters for the early detection of myocardial changes and prediction of cardiotoxicity in patients receiving cancer therapy is confirmed.
Journal ArticleDOI
Relative ‘apical sparing’ of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis
Dermot Phelan,Patrick Collier,Paaladinesh Thavendiranathan,Zoran B. Popović,Mazen Hanna,Juan Carlos Plana,Thomas H. Marwick,James D. Thomas +7 more
TL;DR: A relative ‘apical sparing’ pattern of LS is an easily recognisable, accurate and reproducible method of differentiating CA from other causes of LV hypertrophy.
Journal ArticleDOI
Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
Heloisa Sawaya,Igal A. Sebag,Juan Carlos Plana,James L. Januzzi,Bonnie Ky,Bonnie Ky,Timothy C. Tan,Victor Cohen,Jose Banchs,Joseph R. Carver,Joseph R. Carver,Susan E. Wiegers,Susan E. Wiegers,Randolph P. Martin,Michael H. Picard,Robert E. Gerszten,Elkan F. Halpern,Jonathan J. Passeri,Irene Kuter,Marielle Scherrer-Crosbie +19 more
TL;DR: In this article, the authors investigated whether early alterations of myocardial strain and blood biomarkers predict incident cardiotoxicity in patients with breast cancer during treatment with anthracyclines, taxanes, and trastuzumab.